PUT - SPRINTER OPEN END - IDEXX LABORATORIES Stock

Certificat

DE000VM6FL34

Real-time Boerse Frankfurt Warrants 04:21:38 2024-06-24 am EDT
1.76 EUR -1.68% Intraday chart for PUT - SPRINTER OPEN END - IDEXX LABORATORIES
Current month+2.29%
1 month+21.77%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-24 1.76 -1.68%
24-06-21 1.79 +2.29%
24-06-20 1.75 +4.17%
24-06-19 1.68 0.00%
24-06-18 1.68 -1.18%

Real-time Boerse Frankfurt Warrants

Last update June 24, 2024 at 04:21 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying IDEXX LABORATORIES, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM6FL3
ISINDE000VM6FL34
Date issued 2023-12-05
Strike 682.3 $
Maturity Unlimited
Parity 100 : 1
Emission price 1.56
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.95
Lowest since issue 0.94
Spread 0.03
Spread %1.69%

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
495.7 USD
Average target price
564.1 USD
Spread / Average Target
+13.80%
Consensus